Anti-CD20 Antibody (Ublituximab)
Catalog No.
F1181
Anti-CD20 Antibody (Ublituximab)
Featured Products
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation type 1 chimeric monoclonal antibody that targets a unique epitope on the CD20 antigen. Ublituximab has anticancer effects.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1174014-05-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
LFB-R603, R603
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P11836
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD20
Please avoid freeze-thaw cycles.